GENECURE Trademark

Trademark Overview


On Friday, August 10, 2007, a trademark application was filed for GENECURE with the United States Patent and Trademark Office. The USPTO has given the GENECURE trademark a serial number of 77252837. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 29, 2018. The GENECURE trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral ...
genecure

General Information


Serial Number77252837
Word MarkGENECURE
Filing DateFriday, August 10, 2007
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 29, 2018
Registration Number3491505
Registration DateTuesday, August 26, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2008

Trademark Statements


Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceuticals, namely, anti-infectives
Pseudo MarkGENE CURE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 15, 2007
Primary Code005
First Use Anywhere DateWednesday, September 30, 1998
First Use In Commerce DateFriday, January 1, 1999

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressDuluth, GA 30096

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressDuluth, GA 30096

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDuluth, GA 30096

Trademark Events


Event DateEvent Description
Wednesday, August 29, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 29, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, August 29, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, August 29, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 20, 2018TEAS SECTION 8 & 9 RECEIVED
Monday, August 20, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 26, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, December 9, 2013NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, December 9, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, December 2, 2013REGISTERED - SEC. 8 (6-YR) FILED
Monday, December 9, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 2, 2013TEAS SECTION 8 RECEIVED
Monday, December 2, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 26, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, June 10, 2008PUBLISHED FOR OPPOSITION
Wednesday, May 21, 2008NOTICE OF PUBLICATION
Monday, May 5, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 5, 2008ASSIGNED TO LIE
Monday, May 5, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 2, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 1, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 1, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 11, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 11, 2008NON-FINAL ACTION E-MAILED
Friday, January 11, 2008NON-FINAL ACTION WRITTEN
Thursday, January 10, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 8, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 8, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 19, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 19, 2007NON-FINAL ACTION E-MAILED
Monday, November 19, 2007NON-FINAL ACTION WRITTEN
Friday, November 16, 2007ASSIGNED TO EXAMINER
Wednesday, August 15, 2007NEW APPLICATION ENTERED IN TRAM